Want to join the conversation?
$JNJ's Alios BioPharma said new data published in New England Journal of Medicine shows potential of compound to fight respiratory syncytial virus (RSV) infection. This Phase 2a study now established human proof-of-concept for antiviral activity of ALS-008176 in healthy adults and highlights potential as therapy for managing clinical disease.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!